The industry's evolving, so are we

Article

Sometimes I sit back and think about how this magazine has evolved over the years and, on a more regular basis, I think about where we can go from here.

Sometimes I sit back and think about how this magazine has evolved over the years and, on a more regular basis, I think about where we can go from here.

I often call upon the advice of our esteemed Editorial Advisory Board members to guide the editorial direction of this magazine; however, the thoughts of our readers are also of paramount importance. As such, I am incredibly grateful to you for your involvement in readership surveys and for the comments I have received from you by E-mail and at congresses. This really has helped us to serve you better.

As the ophthalmology industry evolves, so too do your needs and as such, we want to make sure that we are providing you with exactly what you want, when you want it.

This is just one example of some of the changes that we are making. Please do keep your suggestions coming because we are listening and every one of your opinions and ideas is taken on board. Ultimately, Ophthalmology Times Europe is your information source so make sure it's perfect for you.

Best wishes,

Fedra Pavlou
Editor
[email protected]

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.